IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia (IVICA)
An Open Label Study to Determine the Efficacy of Ferric Carboxymaltose in Preoperative Colorectal Cancer Related Anaemia, and to Develop Biomarkers to Predict Response to This Treatment Strategy
Sponsor: National Institute for Health Research, United Kingdom
A PHASE4 clinical study on Anemia and Colorectal Neoplasm, this trial is completed. The trial is conducted by National Institute for Health Research, United Kingdom and has accumulated 5 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Apr 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute for Health Research, United Kingdom
- Nottingham University Hospitals NHS Trust
For direct contact, visit the study record on ClinicalTrials.gov .